Visit the News Hub
Some labs remain active, with focus switched to COVID-19
A School of Medicine lab member packs up items in a lab in the Couch Biomedical Research Building. Research in most of the universities' labs has been ramped down due to the COVID-19 pandemic.
When Washington University Vice Chancellor for Research Jennifer K. Lodge, PhD, first sounded the alarm about the disruptive impact COVID-19 likely would have on labs across the university, the research community heeded her warning, taking steps to shut down lab work and move as much as possible online.
Those in position to do so began pivoting their research to the novel coronavirus that has caused an unprecedented shutdown of public life across the globe. In a very short span of time, the universitys scientific community has responded to the pandemic with extraordinary research collaborations, all the while finding new ways to keep faculty, staff and students connected as they shift work out of the lab and into cyberspace.
For all of us who are passionate about our research, we know that ramping down and pausing our work is very difficult, said Lodge, a professor of molecular microbiology who also serves as associate dean of research for the School of Medicine. At the same time, this unusual situation may provide a rare opportunity for researchers to slow down our typically fast pace and think deeply about our science and connect with colleagues in ways we havent before.
Scientific research is a complex endeavor, and figuring out how to slow or stop research that might involve living cells or mice is not a simple task. The Office of the Vice Chancellor for Research is constantly updating its coronavirus information website, Guidance for Researchers on COVID-19, and recommends that investigators frequently refresh the site to check for updates on the fast-changing advice and resources available to researchers, including updates from funding agencies, such as the National Institutes of Health (NIH). The office also has held virtual town hall meetings via Zoom to keep researchers up to date.
Sarah K. England, PhD, the Alan A. and Edith L. Wolff Professor of Medicine, has moved much of her lab online and set up a small, rotating group of people to take care of lab tasks that need to continue, even during a shutdown. Englands lab focuses on studies of the uterus and factors that might lead to preterm birth.
We immediately made sure everyone has access to their data online, through Box, so that we all can work remotely, England said. Fortunately, quite a few people in my lab can focus on writing or new project planning. We still have a skeleton crew going into the lab to check on things we absolutely must check on. We set up an online calendar showing when people are going in so theres no overlap and we can maintain safe physical distancing. Its been helpful to have somebody there because we also were able to collect PPE to donate to coronavirus-focused clinical efforts.
Farshid Guilak, PhD, a professor of orthopedic surgery, described similar steps taken in his lab. Many labs, including his and Englands, are trying to maintain special colonies of mice. Even though active research may have stopped, it is important to continue caring for these groups of mice with special genetics and other characteristics that make them unique, so that work can ramp up again quickly when researchers are able to return to the lab. As a backup, researchers also have cryopreserved embryos of such specialized mice to ensure their survival.
Fortunately, at this point, we are able to continue to feed our mice their special diets, Guilak said. We study models of obesity and how that might increase the risk of developing arthritis. Were doing our best to minimize the impact of not having our typical access to the mice.
This lab in the Couch Biomedical Research Building normally would be bustling with activity but has been quieted due to a research rampdown ordered in response to the COVID-19 pandemic.
The School of Medicines COVID-19 task force orchestrating research into the novel coronavirus is led by Jeffrey Milbrandt, MD, PhD, the James S. McDonnell Professor and head of the Department of Genetics; William G. Powderly, MD, the J. William Campbell Professor of Medicine and director of the Institute for Clinical and Translational Sciences (ICTS); and Sean Whelan, PhD, the Marvin A. Brennecke Distinguished Professor and head of the Department of Molecular Microbiology. A major focus of this work includes creating mouse models of COVID-19 infection and vaccine development.
In addition, researchers who study other viruses, lung infections or have other related expertise are turning their labs resources to the novel coronavirus. Shabaana Khader, PhD, a professor of molecular microbiology, studies tuberculosis (TB); and Jacco Boon, PhD, an associate professor of medicine, is focused on influenza viruses. Both are uniquely positioned to trade research into one dangerous lung infection for another.
Because we study other types of respiratory viruses, our lab is ideally equipped to conduct basic research on the COVID-19 virus, Boon said. We can grow the virus in our facility and, once we have animal models, we can start testing new compounds and antibodies for potential treatments. One challenge is that mice dont have the lung receptor that this virus targets to infect human lungs. One solution could be to genetically modify mice to express the human lung receptor.
Khader studies the lungs immune response to tuberculosis (TB) infection. Her team could, potentially, help shed light on how the immune system in the lungs reacts to coronavirus infection. As part of her TB research, Khader works with a collaborator at the Texas Biomedical Research Institute, Deepak Kaushal, PhD. Kaushal studies TB infection in macaques, nonhuman primates that have the lung receptor for COVID-19 infection.
When we receive lung samples from his group, we will be using single cell technology to study the lung immunology of this disease, Khader said. We will be able to look at the immune response over time and how it might change from the first few days of infection to longer time points. So, my lab is shutting down our TB operations and ramping up COVID-19 work.
Even investigators whose research might seem to have little to do with respiratory viruses are exploring aspects of COVID-19, such as investigating ways the pandemic is influencing childhood development. Deanna M. Barch, PhD, the Gregory P. Couch Professor and head of the Department of Psychological & Brain Sciences, co-leads the Adolescent Brain and Cognitive Development Study, a national study with multiple clinical sites involving a broad sample of children across the country. As much as possible, the studys assessments have been moved online.
We are adding assessments that directly address COVID-19 in terms of its impacts on families and kids, Barch said. We would like to understand what factors may predict resilience in this stressful situation and how that might impact brain development over time.
Lori A. Setton, PhD, the Lucy and Stanley Lopata Distinguished Professor and chair of the Department of Biomedical Engineering, said that several professors in her department also have pivoted their research to COVID-19, including studying the heart arrhythmia that some patients experience.
She also talked about supporting faculty members who are teaching online for the first time while ramping down work in their labs.
I held drop-in coffee hours on Zoom, so faculty members could tell me what they needed to help with the transition, Setton said. Many lab groups are holding virtual happy hours to have more casual discussions about their transitions to remote work and their research strategies moving forward. There are a lot of humorous and uplifting stories about these transitions that it has helped to share.
Setton, Khader, England, Guilak and others also talked about the importance of maintaining social ties during this time of social distancing, and providing support for their lab members physical and mental well-being.
Labs are little communities, and many of our trainees are far from home, so were concerned about everyones mental health, Guilak said. Were trying to check in with everybody on a regular basis. Were continuing our regular lab meetings online and then having smaller group meetings every week. Several of our trainees have started their own journal clubs. All of this is over Zoom or otherwise online, but its important to maintain the connections.
Added England: Many of our people have young children at home, and were trying to make sure everyone has the time and ability to adjust to the challenges of working from home for a while.
Many labs and groups around campus have found ways to use Slack to stay connected. Guilak said his lab has a Slack channel called Positivity, where they share photos of kids and pets and trade recipes and cooking tips.
I am inspired by the response of the Washington University community to this unprecedented situation, Lodge said. Thank you to those who have switched their work to COVID-19. And thank you to everyone who has taken steps to ramp down all other research in their labs and work remotely to keep as many people off campus as possible. Together, we are doing our best to bend the curve and help protect our clinical colleagues on the front lines fighting this virus.
Postdoctoral researchers Brett Case, PhD, (left) and Adam Bailey, MD, PhD, wear full personal protective equipment to study the COVID-19 virus. Washington University School of Medicine in St. Louis physicians and researchers are preparing for COVID-19 cases and working on drugs and vaccines to fight the disease.
Washington University School of Medicines 1,500 faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Childrens hospitals. The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Childrens hospitals, the School of Medicine is linked to BJC HealthCare.
Go here to read the rest:
- Podcast 9 Athens part 3 and news - November 8th, 2009 [November 8th, 2009]
- Podcast 10 Athens part 4 - November 8th, 2009 [November 8th, 2009]
- Podcast 11 Athens Part 5 - November 8th, 2009 [November 8th, 2009]
- Episode 12 Cardiac Nuclear Medicine in the UK - November 8th, 2009 [November 8th, 2009]
- Podcast 13 Choline PET and prostate cancer - November 8th, 2009 [November 8th, 2009]
- Episode14 ED function and Dysponea - November 8th, 2009 [November 8th, 2009]
- ep 15 Collimator Choice and Reconstruction algorithm - November 8th, 2009 [November 8th, 2009]
- Episode 16 Dr Strauss on vulnerable plaque - November 8th, 2009 [November 8th, 2009]
- Episode17 Chemical Stress - November 8th, 2009 [November 8th, 2009]
- Episode 18 Myocardial Perfusion Imaging and Diabetes - November 8th, 2009 [November 8th, 2009]
- Episode 19 The INSPIRE trial - November 8th, 2009 [November 8th, 2009]
- 20 Dual isotope with a difference - November 8th, 2009 [November 8th, 2009]
- Episode 21 The real effect of stress - November 8th, 2009 [November 8th, 2009]
- Episode 22 D-SPECT - November 8th, 2009 [November 8th, 2009]
- Episode 23 VQ Reprise - November 8th, 2009 [November 8th, 2009]
- Episode 24 Hepatobiliary Nuclear Medicine - November 8th, 2009 [November 8th, 2009]
- Episode 25 Sleep Apnea - November 8th, 2009 [November 8th, 2009]
- Episode 26 Imaging Post Traumatic Stress Disorder - November 8th, 2009 [November 8th, 2009]
- Episode 27 Cardiac Stem Cells - November 8th, 2009 [November 8th, 2009]
- Episode 28 Molly Supply - November 8th, 2009 [November 8th, 2009]
- Episode 29 Melanoma therapy interview with Dr Ekaterina Dadachova - November 8th, 2009 [November 8th, 2009]
- Episode 30 Viral Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 31 breast radiotherapy using radioisotopes - November 8th, 2009 [November 8th, 2009]
- Episode 32 news from snm - November 8th, 2009 [November 8th, 2009]
- Episode 33 EBV Imaging and Therapy - November 8th, 2009 [November 8th, 2009]
- Episode 34 Dr Lele SNM India 2009 - December 14th, 2009 [December 14th, 2009]
- Episode 35 Dr Andrew Scott from the Ludwig institute - January 10th, 2010 [January 10th, 2010]
- Episode 36 CardiArc - February 25th, 2010 [February 25th, 2010]
- Episode 37 Dr Modder Radiosynoviorthesis (Radiation Synovectomy) - March 31st, 2010 [March 31st, 2010]
- Episode 38 Indian Nuclear Medicine With Dr Malhotra and Dr Krishna - May 28th, 2010 [May 28th, 2010]
- Episode 39 Prof Ora Israel The Utility of Hybrid Imaging - July 13th, 2010 [July 13th, 2010]
- Episode 40 New V/Q SPECT developments - October 11th, 2010 [October 11th, 2010]
- Episode 41 scintimun - February 14th, 2011 [February 14th, 2011]
- Episode 42 Radio-Isotope Supply into the future - March 6th, 2011 [March 6th, 2011]
- Podcast 4: DNA therapy - April 24th, 2011 [April 24th, 2011]
- Sorry about the delay a new podcast will be out soon! - April 24th, 2011 [April 24th, 2011]
- Podcast 5 Flash 3D - April 24th, 2011 [April 24th, 2011]
- Podcast 6 Affibody - April 24th, 2011 [April 24th, 2011]
- Podcast 7 EANM 2006 Athens Part 1 - April 24th, 2011 [April 24th, 2011]
- Podcast 8 Athens Part 2 - April 24th, 2011 [April 24th, 2011]
- Episode 43 Rapidscan Part 1, 720P high quality video version - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Ipod quality video - May 1st, 2011 [May 1st, 2011]
- Episode 43 Rapidscan Part 1, Audio version - May 1st, 2011 [May 1st, 2011]
- Episode 45 Mummies with cardiovascular disease video - May 21st, 2011 [May 21st, 2011]
- Episode 45 Mummies with cardiovascular disease audio edition - May 21st, 2011 [May 21st, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective - August 7th, 2011 [August 7th, 2011]
- Episode 46 Dr Gordon DePuey Choosing Reconstruction clinical perspective audio version - August 7th, 2011 [August 7th, 2011]
- Episode 47 Cardiac Image Fusion With Dr Kaufmann - September 18th, 2011 [September 18th, 2011]
- Episode 47 Cardiac Fusion with Dr Kaufmann video version - September 18th, 2011 [September 18th, 2011]
- Dear Steve, I am and many more like me are your one more thing. - October 9th, 2011 [October 9th, 2011]
- EPISODE 48 PET MRI camera from Siemens with Dr Georgi audio - October 23rd, 2011 [October 23rd, 2011]
- EPISODE 48 PET MRI camera from Siemens Dr Georgi video - October 23rd, 2011 [October 23rd, 2011]
- Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit - April 25th, 2012 [April 25th, 2012]
- Leukaemia cells have a remembrance of things past - April 25th, 2012 [April 25th, 2012]
- Technologist Education Requirements Can Help Cut Repeat Scans - April 25th, 2012 [April 25th, 2012]
- HKU Collaborative Research Discovers A Novel Molecular Mechanism Of A New Anti-HIV-1 Drug Candidate - April 25th, 2012 [April 25th, 2012]
- Focal Segmental Glomerulosclerosis and the Nephrotic Syndrome - Part 1 Clinical - Video - May 4th, 2012 [May 4th, 2012]
- Electro-Medicine : Biological Physics - The Molecular Basis of Alzheimers Disease - Video - May 4th, 2012 [May 4th, 2012]
- osdd heterocyclic compounds and molecular medicines - Video - May 4th, 2012 [May 4th, 2012]
- Molecule to Medicine: The Biomarker Frontier - Video - May 4th, 2012 [May 4th, 2012]
- Fulfilling the Promise of Molecular Medicine in a Developmental Brain Disorder - Video - May 4th, 2012 [May 4th, 2012]
- Focus on Stefanie Dimmeler - Video - May 4th, 2012 [May 4th, 2012]
- Dundee - May 4th, 2012 [May 4th, 2012]
- Nanotechnology In Medicine: Huge Potential, But What Are The Risks? - May 5th, 2012 [May 5th, 2012]
- Cutting Edge Technology Coming To DMH - May 5th, 2012 [May 5th, 2012]
- This Week in Experimental and Molecular Pathology - May 5th, 2012 [May 5th, 2012]
- Researchers' discovery offers hope for cancer, heart disease miracle drugs - May 7th, 2012 [May 7th, 2012]
- Penn State student Zachary Hostetler from Garnet Valley is being honored as a student marshal - May 7th, 2012 [May 7th, 2012]
- NCKU Student Wins Prestigious Award for Anti-Cancer Research - May 10th, 2012 [May 10th, 2012]
- In-Vitro Diagnostics (IVD) Market (Clinical Chemistry, Immunoassays, Molecular Diagnostics, Hematology Analyzers ... - May 10th, 2012 [May 10th, 2012]
- Pitt team uses genomics to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- Genomics used to identify a molecular-based treatment for a viral skin cancer - May 10th, 2012 [May 10th, 2012]
- 2 molecular biologists get $500K medical prize - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists share $500K medical prize - May 13th, 2012 [May 13th, 2012]
- Lab21 Unveils New Molecular Analysis Services at Greenville Site - May 13th, 2012 [May 13th, 2012]
- 2 molecular biologists from NYC to share $500K medical prize for pioneering research on cells - May 13th, 2012 [May 13th, 2012]
- Two Molecular Biologists Get $500K Medical Prize - May 13th, 2012 [May 13th, 2012]
- Pair of molecular biologists receive Albany Medical Center Prize - May 13th, 2012 [May 13th, 2012]
- CNIO scientists successfully test the first gene therapy against aging-associated decline - May 16th, 2012 [May 16th, 2012]
- Cancer Institute of New Jersey Aims to Advance Personalized Cancer Treatments Through 'Precision Medicine' - May 16th, 2012 [May 16th, 2012]